Clinical Trial Update: 129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of Exacerbation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on a 129-Xe MRI study evaluating a single triple therapy inhaler in COPD patients, with status NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Single Triple Therapy Inhaler

Snippet

Sponsor: Western University, Canada | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Status: NOT_YET_RECRUITING